Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Michael D. Celestin Jr PhD
Population Sciences
LSU Health - New Orleans
Jean Christopher Chamcheu PhD
Translational Oncology
University of Louisiana Monroe
Andrew G. Chapple PhD
Population Sciences
LSU Health - New Orleans
YiPing Chen PhD
Cancer Biology
Tulane University School of Medicine
John Cole MD
Translational Oncology
Ochsner Health
Cathi Cox-Boniol
Population Sciences
Louisiana Tech University
Santosh D'Mello PhD
Translational Oncology
LSU Health - Shreveport
Srikanta Dash PhD
Cancer Biology
Tulane University School of Medicine
Heidi Davis, PhD
Population Sciences
Ochsner Health